112 related articles for article (PubMed ID: 7419671)
1. Estrogen receptors in human pituitary adenomas.
Pichon MF; Bression D; Peillon F; Milgrom E
J Clin Endocrinol Metab; 1980 Oct; 51(4):897-902. PubMed ID: 7419671
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptors in human pituitary tumors.
Burdman JA; Pauni M; Heredia Sereno GM; Bordón AE
Horm Metab Res; 2008 Aug; 40(8):524-7. PubMed ID: 18398784
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study.
Bression D; Brandi AM; Martres MP; Nousbaum A; Cesselin F; Racadot J; Peillon F
J Clin Endocrinol Metab; 1980 Nov; 51(5):1037-44. PubMed ID: 7419680
[TBL] [Abstract][Full Text] [Related]
7. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
[TBL] [Abstract][Full Text] [Related]
9. Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.
Le Dafniet M; Brandi AM; Bression D; Racadot T; Peillon F
J Clin Endocrinol Metab; 1983 Aug; 57(2):425-7. PubMed ID: 6306043
[TBL] [Abstract][Full Text] [Related]
10. Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.
Bression D; Brandi AM; Nousbaum A; Le Dafniet M; Racadot J; Peillon F
J Clin Endocrinol Metab; 1982 Sep; 55(3):589-93. PubMed ID: 7096541
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.
Zafar M; Ezzat S; Ramyar L; Pan N; Smyth HS; Asa SL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610
[TBL] [Abstract][Full Text] [Related]
12. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
13. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of specific dopamine receptors on human pituitary adenomas.
Koga M; Nakao H; Arao M; Sato B; Noma K; Morimoto Y; Kishimoto S; Mori S; Uozumi T
Acta Endocrinol (Copenh); 1987 Apr; 114(4):595-602. PubMed ID: 3577589
[TBL] [Abstract][Full Text] [Related]
15. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-immunoassay for estrogen receptors in human pituitary adenomas.
Nakao H; Koga M; Arao M; Nakao M; Sato B; Kishimoto S; Saitoh Y; Arita N; Mori S
Acta Endocrinol (Copenh); 1989 Feb; 120(2):233-8. PubMed ID: 2916384
[TBL] [Abstract][Full Text] [Related]
17. Specific somatostatin receptors on human pituitary adenoma cell membranes.
Ikuyama S; Nawata H; Kato K; Karashima T; Ibayashi H; Nakagaki H
J Clin Endocrinol Metab; 1985 Oct; 61(4):666-71. PubMed ID: 2863281
[TBL] [Abstract][Full Text] [Related]
18. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.
Reubi JC; Heitz PU; Landolt AM
J Clin Endocrinol Metab; 1987 Jul; 65(1):65-73. PubMed ID: 3034958
[TBL] [Abstract][Full Text] [Related]
19. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC
J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
